La sindrome di Down : una questione di “geni”


[1] Aït Yahya-Graison, E. et al. “Classification of Human Chromosome 21 Gene-Expression Variations in Down Syndrome: Impact on Disease Phenotypes.” American Journal of Human Genetics 81.3 (2007): 475–491. Print.

[2]Rachidi, M., & Lopes, C. (2011). Mental Retardation and Human Chromosome 21 Gene Overdosage: From Functional Genomics and Molecular Mechanisms Towards Prevention and Treatment of the Neuropathogenesis of Down Syndrome. In J. D. Clelland (Ed.), Genomics, Proteomics, and the Nervous System (pp. 21–86). New York, NY: Springer New York.

[3] Donna M Wilcock and W Sue T Griffin* Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis Journal of Neuroinflammation 2013, 10:84 doi:10.1186/1742-2094-10-84

[4] Walter Becker, Ulf Soppa and Francisco J. Tejedor,DYRK1A: A Potential Drug Target for Multiple Down Syndrome Neuropathologies,CNS & Neurological Disorders – Drug Targets ,volume 13, issue 1, pages 26-33, year 2014, issn 1871-5273/1996-3181, doi 10.2174/18715273113126660186,

Letture interessanti: